China: Corporate and Company Law

数据产权的法律性质长期不明，构成数据要素市场化配置的规范瓶颈。最高人民法院第47批指导性案例264号首次在司法裁判中系统运用

2022年最高人民法院《关于审理证券市场虚假陈述侵权民事赔偿案件的若干规定》（法释〔2022〕2号，以下简称“《虚假陈述若干规定》”）第10条确立了价格影响标准（即《虚假陈述若干规定》第10条所称“交易价格或者交易量”是否受到影响的判断标准，本文简称价格影响标准），为被告提供了推

近日，中国证监会严肃查处了私募基金玖瀛资产、腾创投资违法违规案件，暴露出部分私募机构在资金运作、关联交易及投资者权益保护方面的严重缺陷；上月初，国务院办公厅印发《关于加强监管防范风险促进私募投资基金高质量发展的指导意见》，从顶层设计上强化了私募基金监管框架A

A detailed case analysis examining how Chinese courts determine liability for shareholders and related parties when a bankrupt company cannot be liquidated due to missing financial records. Through a landmark case where the second instance court reversed a complete first instance judgment, this article explores the evolution of judicial standards in bankruptcy derivative litigation.

最高法在（2023）最高法知民终2880号案侵害技术秘密纠纷一案中，推翻一审法院对涉案技术信息包含的多个秘点逐一拆解分析后认定的方式，对涉案技术信息进行整体认定、给予整体保护，最终撤销一审判决，全面改判。最高法在该案中适用的整体认定、整体保护裁判规则，对于类案处理具有重#

近年来，随着私募基金行业的快速发展，“强监管、防风险”已成为行业主旋律，穿透式监管态势日益趋严。在募、投、管、退的全生命周期中，如何坚守合规底线？当管理人触碰刑事红线时，法律定性边界何在？而在风险爆发后，投资者又该如何在民刑交叉的复杂局面中寻找最优维权路径ᦃ

On June 1, 2026, China’s State Council issued the Regulation on Outbound Investment (the “Regulation”), which will take effect on July 1, 2026. This is China’s first State Council administrative regulation dedicated...

On May 7, 2026, China’s National Medical Products Administration (NMPA), in conjunction with six other government agencies, issued the Management Measures for Medical Representatives (Management Measures, 医药代表管理办法), which will take effect on August 1, 2026.

In recent years, with the increasing adoption of remote working models, insurance companies in China have been exploring more flexible employment and office arrangements, including work from home, cross-regional working, and sharing office space.